Aion Therapeutic Inc.
AION
CNSX
| 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 261.10K | 700.00 | 300.00 | 200.00 | -- |
| Total Receivables | 95.20K | 212.90K | -- | 145.50K | 133.60K |
| Inventory | 299.20K | -- | -- | -- | -- |
| Prepaid Expenses | 5.80K | 1.30K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 13.30K | -- | -- | -- |
| Total Current Assets | 661.20K | 228.20K | -- | 145.80K | 133.60K |
|
|
|||||
| Total Current Assets | 661.20K | 228.20K | -- | 145.80K | 133.60K |
| Net Property, Plant & Equipment | 139.80K | -- | -- | -- | -- |
| Long-term Investments | 3.59M | -- | -- | -- | -- |
| Goodwill | 3.59M | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.40M | 237.50K | -- | 155.40K | 470.60K |
|
|
|||||
| Total Accounts Payable | 1.90M | 1.27M | -- | 1.24M | 1.00M |
| Total Accrued Expenses | 211.10K | 154.60K | -- | 209.10K | 163.20K |
| Short-term Debt | 1.45M | 748.20K | -- | 715.50K | 703.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 70.70K | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.63M | 2.17M | -- | 2.17M | 1.87M |
|
|
|||||
| Total Current Liabilities | 3.63M | 2.17M | -- | 2.17M | 1.87M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.45M | 748.20K | -- | 715.50K | 703.50K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.63M | 2.17M | -- | 2.17M | 1.87M |
|
|
|||||
| Common Stock & APIC | 14.82M | 11.39M | -- | 11.19M | 11.38M |
| Retained Earnings | -15.67M | -14.82M | -- | -14.81M | -14.51M |
| Treasury Stock & Other | 1.63M | 1.49M | -- | 1.60M | 1.73M |
| Total Common Equity | 772.00K | -1.94M | -2.07M | -2.01M | -1.40M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 772.00K | -1.94M | -2.07M | -2.01M | -1.40M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 772.00K | -1.94M | -2.07M | -2.01M | -1.40M |
|
|
|||||
